新東方等被北京市教委點名批評收取超過三個月課時費用
內地首都教育微信公眾號指,北京市教委對北京市校外培訓機構進行檢查時,發現部分機構存在違規問題,包括新東方(09901.HK)、學而思以及上海英之界教育科技等,存在一次性收取或變相收取超過三個月或60課時費用。
同時被批評的亦包括擅自恢復線下課程、開展低價營銷、販賣焦慮等不當廣告宣傳,以及教學內容超出國家相應課程標準的培訓機構等。北京市教委要求對檢查中發現有關問題,各區要高度重視、督促整改,並將整改情況報市教委。
上月北京市市場監管局對跟誰學(GOTU.US)、新東方在線(01797.HK)、學而思、高思四家校外教育培訓機構,因價格違法、虛假宣傳等行為分別給予警告和50萬元人民幣頂格罰款的行政處罰。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.